# DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses

> **NCT04479748** · PHASE4 · COMPLETED · sponsor: **Prism Vision Group** · enrollment: 13 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Prednisolone Acetate 1% Oph Susp

## Key facts

- **NCT ID:** NCT04479748
- **Lead sponsor:** Prism Vision Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04479748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04479748, "DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04479748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*